NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
Clinical Trials
4 trialsNCT04607850 2025-08-28
Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions
Barinthus Biotherapeutics
Phase 1/2 Completed
NCT02535104 2018-06-06
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
Tamir Biotechnology, Inc.
Phase 1/2 Completed
NCT01532102 2018-05-30
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
Vaxart
Phase 1/2 Completed